OPS — Opsens Share Price
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- CA$334.82m
- CA$325.92m
- CA$48.35m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.9 | ||
| Price to Tang. Book | 10.41 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 6.93 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -28.83% | ||
| Return on Equity | -36.43% | ||
| Operating Margin | -25.08% | ||
Financial Summary
| Year End 31st Aug | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 32.75 | 29.45 | 34.46 | 35.32 | 48.35 | 65.72 | 93.87 | 14.97% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
OpSens Inc. is a medical device cardiology-focused company. The Company offers an advanced optical-based pressure guidewire that aims at improving the clinical outcome of patients with coronary artery disease. The Company’s segments include Medical and Industrial. The Medical segment focuses on physiological measurements, such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and also supplies a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated into other medical devices. The Industrial segment develops, manufactures and installs fiber optic sensing solutions for critical and demanding industrial applications. Its flagship product, the OptoWire, is a second-generation fiber optic pressure guidewire designed to provide the lowest drift in the industry and lesions access. It is approved for sale in the United States, European Union, Japan and Canada.
Directors
- Alan Milinazzo CHM (61)
- Louis Laflamme PRE
- Robin Villeneuve CFO (54)
- Gaetan Duplain CEX
- Lori Chmura IND
- Denis Harrington IND
- Jean Lavigueur IND
- James Mackin IND
- Denis Sirois IND
- Last Annual
- August 31st, 2023
- Last Interim
- August 31st, 2023
- Incorporated
- February 28th, 2006
- Public Since
- January 1st, 1970
- No. of Employees
- 293
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Toronto Stock Exchange
- Shares in Issue
- 115,453,608
- Address
- 750, Boul. du Parc Technologique, QUEBEC, G1P 4S3
- Web
- https://opsens.com/
- Phone
- +1 4187810333
- Contact
- Louis Laflamme
- Auditors
- Deloitte LLP
Upcoming Events for OPS
Opsens Inc Annual Shareholders Meeting
Q2 2024 Opsens Inc Earnings Release
Similar to OPS
Bausch + Lomb
Toronto Stock Exchange
Hamilton Thorne
Toronto Stock Exchange
Profound Medical
Toronto Stock Exchange
Sernova
Toronto Stock Exchange
Titan Medical
Toronto Stock Exchange
FAQ
What is the Opsens share price?
As of Today at 06:16 UTC, shares in Opsens are trading at CA$2.90. This share price information is delayed by 15 minutes.
How has the Opsens share price performed this year?
Shares in Opsens last closed at CA$2.90 and the price had moved by +52.63% over the past 365 days. In terms of relative price strength the Opsens share price has outperformed the Toronto Stock Exchange 300 Composite Index by +44.56% over the past year.
What are the analyst and broker recommendations for Opsens?
The overall consensus recommendation for Opsens is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Opsens dividend yield?
Opsens does not currently pay a dividend.
Does Opsens pay a dividend?
Opsens does not currently pay a dividend.
When does Opsens next pay dividends?
Opsens does not currently pay a dividend.
How do I buy Opsens shares?
To buy shares in Opsens you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Opsens?
As of the previous close price of CA$2.90, shares in Opsens had a market capitalisation of CA$334.82m.
Where are Opsens shares listed?
Here are the trading details for Opsens:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: OPS
What kind of share is Opsens?
Based on an overall assessment of its quality, value and momentum Opsens is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Opsens share price forecast for 2023?
The analyst consensus target price for shares in Opsens is CA$3.36. That is 15.86% above the last closing price of CA$2.90.
Analysts covering Opsens currently have a consensus Earnings Per Share (EPS) forecast of -CA$0.04 for the next financial year.
Find out moreWhat is the trend in the Opsens share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Opsens. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +87.73%.
As of the last closing price of CA$2.90, shares in Opsens were trading +45.07% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Opsens PE Ratio?
The Opsens PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$2.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Opsens?
Opsens' management team is headed by:
- Alan Milinazzo - CHM
- Louis Laflamme - PRE
- Robin Villeneuve - CFO
- Gaetan Duplain - CEX
- Lori Chmura - IND
- Denis Harrington - IND
- Jean Lavigueur - IND
- James Mackin - IND
- Denis Sirois - IND